Transdermal Adhesives Market
Transdermal Adhesives Market By Base Chemistry (Silicone Based, Acrylic Based, Rubber Based), By Application (Single-layer drug-in-adhesive Patch, Reservoir Patch, Matrix Patch) & By Region (North America, Europe, MEA) - Global Market Insights 2023 to 2033
Analysis of Transdermal Adhesives Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Transdermal Adhesives Market Growth Outlook (2023 to 2033)
The global transdermal adhesives market is estimated to reach a valuation of US$ 477.3 million in 2023 and it is expected to grow at a CAGR of 7.7% to reach US$ 1,002.2 million by the end of 2033.
Transdermal adhesives are used in a variety of medical applications, including pain management, hormone replacement therapy, and nicotine replacement therapy. It offers a number of advantages over traditional drug delivery methods, such as oral medications or injections, including improved patient compliance, reduced risk of side effects, and more consistent drug delivery.
Transdermal Adhesives Market Size (2022A)
US$ 452.5 Million
Estimated Market Value (2023E)
US$ 477.3 Million
Forecasted Market Value (2033F)
US$ 1,002.2 Million
Global Market Growth Rate (2023–2033)
North America Market Share (2023)
East Asia Market Growth Rate (2023–2033)
Europe Market Share (2023)
East Asia Market Share (2023)
Key Companies Profiled
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Historic and Future Path for Transdermal Adhesives Market
Transdermal adhesives are typically made up of a backing layer, a drug-containing reservoir, and an adhesive layer that is applied to the skin. The adhesive layer is typically made from a soft and flexible material, such as silicone or acrylic, that can conform to the shape of the skin and provide a gentle and secure bond. The drug-containing reservoir may be a gel, a patch, or a cream that is designed to release the drug slowly and steadily over a period of time.
The increasing popularity of wearable devices, such as fitness trackers and smartwatches, is also driving demand for transdermal adhesives. These devices often incorporate sensors that are placed on the skin and require a long-lasting and comfortable adhesive to stay in place.
- Short Term (2023–2026): Increasing chronic disease cases, the use of transdermal patches in hormone replacement therapy, and the increasing demand for transdermal patches for pain management and smoking cessation to drive the transdermal adhesives market.
- Medium Term (2026–2029): Asia Pacific and Europe are anticipated to witness high transdermal adhesives demand on the back of the increasing popularity of wearable devices, growing demand for skin rejuvenation and anti-aging treatments along with favorable regulatory environment for medical devices and pharmaceuticals.
- Long Term (2029–2033): Increased focus on personalized medicine along with investment made by pharmaceutical companies in the development of transdermal delivery systems will drive transdermal adhesives demand in the long term.
Over the 2018-2022 historical period, the global transdermal adhesives market registered a CAGR of 5.2%, according to the Fact.MR, a market research and competitive intelligence provider, the market is projected to exhibit growth at 7.7% CAGR between 2023 and 2033.
Market share analysis of transdermal adhesives based on application and region is provided in a nutshell in the above image. Under the application segment, the multi-layer drug-in-adhesive Patch segment dominates with an 33.4% market share in 2023.
Market Dynamics Overview
“Growing Hospice & Palliative Care Driving the Transdermal Adhesives Market”
Hospice and palliative care are focused on providing comfort and pain management to patients with serious illnesses and can involve the use of medications to manage symptoms. Transdermal patches are a convenient and effective way to deliver medications to patients in these settings.
Transdermal patches can provide a continuous and controlled delivery of medications, which can be particularly useful in managing pain and other symptoms in patients receiving hospice or palliative care. Furthermore, the use of transdermal patches in hospice and palliative care can reduce the need for frequent injections or oral medications, which can be uncomfortable or difficult for patients to tolerate.
As the demand for hospice and palliative care continues to grow, the use of transdermal patches is likely to increase as well. This trend is expected to drive the growth of the transdermal adhesives market, particularly in the healthcare sector.
“Growing Prevalence of Chronic Diseases to Boost Transdermal Adhesive Use”
Chronic pain affects millions of people worldwide and is often treated with oral medications, which can have side effects and can be difficult for some patients to tolerate. Transdermal patches, which deliver pain medications through the skin, can provide more consistent pain relief with fewer side effects.
Transdermal adhesives can provide a consistent and controlled delivery of medication over a prolonged period of time, which can improve treatment outcomes and reduce the need for frequent dosing.
The growth in the pharmaceutical industry, as well as the increasing demand for effective and patient-friendly drug delivery systems, are the major factors driving the growth of the transdermal adhesives market. Additionally, the rising prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, further fuels the demand for transdermal drug delivery systems.
“Factors Restraining the Market Growth”
The production and development of transdermal adhesive products can be costly, which may limit their availability and affordability to a certain extent. Not all drugs can be administered through transdermal patches due to their molecular size, solubility, and other factors.
The regulatory process for approving transdermal patches can be complex and time-consuming. This can delay the launch of new products, and limit the number of products available in the market.
Transdermal patches face competition from other drug delivery systems such as oral tablets, injections, and inhalers. This may limit their adoption in certain therapeutic areas.
Overall, while the transdermal adhesive market has great potential, there may be certain challenges that could impact its growth and expansion.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What is the Market Scenario for Transdermal Adhesives in the U.S.?
The United States is expected to be one of the key countries driving the market growth. This is due to a number of factors such as the growing prevalence of chronic diseases, a large and aging population, increasing healthcare spending, and a favorable regulatory environment for medical devices and pharmaceuticals.
The country also has a large number of pharmaceutical and medical device companies involved in the development and commercialization of transdermal patches. In addition, the United States has a well-established healthcare system with a high level of healthcare expenditure, which supports the development and adoption of advanced healthcare technologies
The United States transdermal adhesives are to expand at a CAGR of 7.6% over the projected period.
Why is India a Lucrative Market for Transdermal Adhesives Manufacturers?
India has a large population with a growing incidence of chronic diseases, including diabetes, hypertension, and cardiovascular diseases, which are some of the major conditions that require effective medication for which transdermal patches play a crucial part.
Furthermore, the Indian government has taken various initiatives to promote healthcare and increase access to healthcare services, which is expected to drive the demand for medical devices, including transdermal patches.
The increasing demand for transdermal patches for pain management, smoking cessation, and hormonal therapy is expected to drive market growth in India. As more patients seek effective and convenient drug delivery options, the demand for transdermal patches is likely to grow, providing a significant opportunity for manufacturers and suppliers of transdermal adhesives.
Due to such favorable factors, India’s market for transdermal adhesives is expected to register a CAGR of 9.4% over the forecast period.
Why are Silicone-based Transdermal Adhesives Dominating the Market?
Silicone-based adhesives are used to deliver a variety of medications, including pain relievers, hormone therapy, and nicotine replacement products. Silicone-based adhesives have better adhesion properties than other adhesives, which ensures that the patch remains in place for the duration of the treatment period. This is especially important for patients who lead an active lifestyle.
In comparison to other adhesives, silicone-based adhesives offer much higher moisture vapor transmission rates and fluid handling capacities, which is an important characteristic that controls patient comfort during prolonged applications.
The demand for silicone based transdermal adhesives is estimated to be valued at US$ 283.1 million in 2023 and is expected to expand at a CAGR of 8.2% during the forecast period.
Why are Multi-layer drug-in-adhesive Patches Gaining Traction?
Multi-layer drug-in-adhesive patches are designed to release drugs in a controlled manner, which ensures that the drug is delivered at a consistent rate over a specific period. This controlled drug release makes multi-layer DIA patches ideal for delivering drugs that require a specific dosage or need to be administered over an extended period.
Overall, the prominent share of multi-layer DIA patches in the transdermal adhesive market can be attributed to their ability to deliver drugs in a controlled manner, their enhanced adhesion, improved comfort, increased drug loading capacity, and versatility.
Owing to the above-mentioned factors, the use of transdermal adhesives for the multi-layer drug-in-adhesive patch is expected to expand at a CAGR of 7.9% in the forecast period to reach a valuation of US$ 340.9 million by 2033.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Prominent transdermal adhesives manufacturers are 3M Company, Adhesives Research, Inc., Adhex Technologies, DuPont, Elkem, Henkel, Lohmann GmbH & Co. KG, and Nitto Denko Corporation.
Key players in the market are focusing on partnering with various end-user to sell their products directly to them. Further, capacity expansion and expanding global footprints by collaboration or acquisition drive the market's growth and provide lucrative opportunities to manufacturers. For instance:
- In 2021, Nitto Denko launched a new line of high-performance adhesive tapes for transdermal patches that offer improved adhesion, flexibility, and durability.
Fact.MR has provided detailed information about the price points of key manufacturers of transdermal adhesives positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segmentation of Transdermal Adhesives Industry Research
By Base Chemistry :
- Silicone Based
- Acrylic Based
- Rubber Based
By Application :
- Single-layer drug-in-adhesive Patch
- Multi-layer drug-in-adhesive Patch
- Reservoir Patch
- Matrix Patch
- Vapour Patch
By Region :
- North America
- Latin America
- East Asia
- South Asia & Oceania
- FAQs -
The global transdermal adhesives market is expected to be valued at US$ 477.3 million in 2023.
Worldwide demand for transdermal adhesives is expected to reach US$ 1,002.2 million by 2033-end.
During 2018-2022, sales of transdermal adhesives increased at 5.2% CAGR.
North America is the crown of the global transdermal adhesives market accounting for 30.4% market share.
Application of transdermal adhesives in multi-layer drug-in-adhesive patches accounts for 33.4% share of global sales.